Pubblicazioni

Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS

2022 - HEPATOLOGY

Queck, Alexander; Schwierz, Louise; Gu, Wenyi; Ferstl, Philip G.; Jansen, Christian; Uschner, Frank E.; Praktiknjo, Michael; Chang, Johannes; Brol, Maximilian J.; Schepis, Filippo; Merli, Manuela; Strassburg, Christian P.; Lehmann, Jennifer; Meyer, Carsten; Trebicka, Jonel

Reply

2021 - HEPATOLOGY

Lamarca, A.; Santos-Laso, A.; Utpatel, K.; La Casta, A.; Stock, S.; Forner, A.; Adeva, J.; Folseraas, T.; Fabris, L.; Macias, R. I. R.; Krawczyk, M.; Krawczyk, M.; Cardinale, V.; Braconi, C.; Alvaro, D.; Evert, M.; Banales, J. M.; Valle, J. W.

Letter to the Editor: Liver Stiffness in Noncirrhotic Portal Hypertension: The Devil Is in the Diagnosis

2019 - HEPATOLOGY

Gioia, S.; Nardelli, S.; Riggio, O.

Interferon lambda 4 rs368234815 TT>Î´G variant is associated with liver damage in patients with nonalcoholic fatty liver disease.

2017 - HEPATOLOGY

Petta, S; Valenti, Laura; Tuttolomondo, A; Dongiovanni, P; Pipitone, Rm; CammÃ , C; Cabibi, D; Di Marco, V; Fracanzani, Al; Badiali, S; Nobili, V; Fargion, S; Grimaudo, S; CraxÃ¬, A.

Gonadotropin-releasing hormone (GnRH) contributes to liver fibrosis in primary sclerosing cholangitis (PSC) through enhanced epithelial-mesenchymal transition (EMT) in small but increased senescence in large cholangiocytes

2016 - HEPATOLOGY

Kyritsi, T; Wu, N; Invernizzi, P; Venter, J; Zhou, Th; Sato, K; Bernuzzi, F; Mcdaniel, K; Onori, Paolo; Franchitto, Antonio; Gaudio, Eugenio; Francis, Hl; Glaser, Ss; Meng, F; Alpini, G.

Inhibition of the substance P/neurokinin-1 receptor (NK-1R) axis decreases liver fibrosis in the Mdr2(-/-) mouse model of primary sclerosing cholangitis (PSC) through changes in senescence in cholangiocytes and hepatic stellate cells

2016 - HEPATOLOGY

Wan, Y; Zhou, Th; Wu, N; Invernizzi, P; Standeford, Ha; Mcdaniel, K; Bernuzzi, F; Venter, J; Onori, Paolo; Gaudio, Eugenio; Franchitto, Antonio; Sato, K; Francis, Hl; Meng, Fy; Alpini, G; Glaser, Ss

The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage

2016 - HEPATOLOGY

Donati, B; Motta, Bm; Pingitore, P; Meroni, M; Pietrelli, A; Alisi, A; Petta, S; Xing, C; Dongiovanni, P; del Menico, B; Rametta, R; Mancina, Rm; Badiali, S; Fracanzani, Al; CraxÃ¬, A; Fargion, S; Nobili, V; Romeo, S; Valenti, L.

Knockdown of the melatonin receptor, MT1, reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated (BDL) mice

2015 - HEPATOLOGYHEPATOLOGY

Wu, N; Meng, Fy; Wan, Y; Venter, J; Standeford, Ha; Francis, Hl; Kennedy, L; Han, Yy; Mcdaniel, K; Franchitto, Antonio; Onori, Paolo; Demorrow, S; Annable, T; Gaudio, Eugenio; Glaser, Ss; Alpini, G.

Down-regulation of the secretin/SR (SCT/SR) axis is coupled with functional biliary damage in dnTGF beta RII mice and human primary biliary cirrhosis (PBC)

2015 - HEPATOLOGYHEPATOLOGY

Kennedy, L; Glaser, Ss; Bernuzzi, F; Meng, Fy; Venter, J; Francis, Hl; Alvaro, D; Gershwin, Me; Franchitto, Antonio; Onori, Paolo; Demorrow, S; Marzioni, M; Gaudio, Eugenio; Invernizzi, P; Alpini, G.

The secretin receptor antagonist (SCT 5-27) reduces biliary hyperplasia and liver fibrosis in an animal model of primary sclerosing cholangitis

2015 - HEPATOLOGYHEPATOLOGY

Wu, N; Meng, Fy; Wan, Y; Venter, J; Bai, Hb; Avila, S; Mcdaniel, K; Standeford, Ha; Onori, Paolo; Gaudio, Eugenio; Alpini, G; Glaser, SS (Glaser

Knockout of the secretin/secretin receptor axis delays regeneration of small and large cholangiocytes by enhanced senescence following 70\% partial hepatectomy (PH)

2015 - HEPATOLOGYHEPATOLOGY

Wan, Y; Glaser, Ss; Wu, N; Meng, Fy; Venter, J; Mancinelli, Romina; Francis, Hl; Franchitto, Antonio; Onori, Paolo; Kyritsi, T; Avila, S; Carpino, G; Standeford, Ha; Alpini, G; Gaudio, Eugenio